Contact
Please use this form to send email to PR contact of this press release:
Actinium Submits Iomab-B IND Application to the U.S. FDA
TO:
Please use this form to send email to PR contact of this press release:
Actinium Submits Iomab-B IND Application to the U.S. FDA
TO: